Theodorus III

Domain Therapeutics is a biopharmaceutical company located in Strasbourg, France, dedicated to the discovery and early development of small molecules targeting G-coupled Protein Receptors (GPCRs), one of the best classes of drug targets. Domain Therapeutics is using its innovative and proprietary technology platform DTect-Allâ„¢ to identify orthosteric and allosteric ligands of GPCRs, including the so called Silent Allosteric Modulators (SAMs) that represent a unique source of compounds that cannot be discovered by standard technologies. DTect-Allâ„¢ is able to address difficult GPCRs such as orphan and peptidic GPCRs.

DrugBank augments human intelligence to improve the world’s health. Our suite of products are powered by the world’s most complete and up-to-date pharmaceutical knowledge database. It includes everything there is to know about drugs and how they work in the body. We enable companies to improve healthcare delivery through precision medicine or clinical software applications, as well as uncover insights through data science in drug discovery. Our knowledge base can be integrated into software solutions to help achieve clinical intelligence. Companies can easily scale their usage through our API and launch faster with flexible data modules. By providing users with advanced insights and the right information at the right time, users are empowered to make better health decisions. Our extensive, structured datasets are used to discover novel drug candidates, identify drug repurposing opportunities, and build predictive machine learning models. Companies working with data science can find answers quickly and get drugs to market faster with our evidence-based drug information. Lastly, our publicly available resource, DrugBank Online, is free-to-use with limited datasets available for download for academic and non-commercial researchers. DrugBank has been cited in over 13,000 academic publications and is used by millions of researchers and health professionals globally.

Contributes to better healthcare thanks to its platform allowing access to structured, validated and anonymised Real World Data.

HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.

Giiant is a preclinical-stage biotech company that, with its proprietary Precision Delivery technology platform, designs gut-restricted, tissue-specific, small molecule, drug therapeutics with various biological targets in gastroenterology. Its lead program GT-2108 is a microbiota-activated PDE4 inhibitor prodrugs, with improved drug tolerability and enhanced therapeutic effect.

Classcraft is an online educational RPG game. It helps teachers manage their classes and make lessons more engaging. The game is available for Android, iOS, OS X, Chrome, and Windows platforms. It was founded by Lauren Young, Devin Young, Shawn Young, and Devin Young.

ChromaCure will launch a drug development program to identify potential new candidates that selectively and potently inhibit cancer targets and potentially provide novel therapy for multiple forms of cancer, either as monotherapy or in combination with immunotherapy or chemotherapy.

VIRTEO’s platform covers the internal dunning and all external (amical/judicial) debt collection processes. With VIRTEO, creditors reduce costs, improve results and enforce CSR policy with external partners like lawyers and bailiffs. VIRTEO helps achieve economic goals (getting paid) with socially responsible practices (avoiding malpractices and excessive costs to debtors). VIRTEO is an online platform allowing credit managers to work directly with lawyers, court bailiffs and recovery agencies in an efficient, transparent and compliant process. The debt collection industry rarely has a positive image. Customers lack tools to monitor and control the practices used by their external collection partners and the goal (recovering the unpaid invoice) is often in contradiction with a socially responsible approach. VIRTEO empowers creditors with a better process and results, and also provides better control over the practices used by their external partners. We provide the customer with the tools and insights to enforce and monitor their CSR policy, while improving results and reducing costs at the same time. Virteo - Where financial fitness meets ethics

Pharmafluidics is a spin-off company of the Vrije Universiteit Brussel, aiming at developing integrated milli- to nano-engineered solutions for mixing, separation and reaction processes. Rooted in chemical engineering with an advanced know-how in micro-fabrication technology, our team specializes in developing high quality and tailor-made solutions for any problem in the chemical and life sciences industry potentially benefiting from miniaturization or fine material structuring.

Acar'Up develops and design a trap device designed to extract and kill the allergenic dust mites living in mattresses, chairs, carpets and other upholstered furniture.

X4C creates molecular coatings for life science applications. They offer solutions for in vitro diagnostic applications. They provide nanoparticles, calixarenes, and tailor-made services.

Domobios is the maker of Acar’up, a trap device, very easy to use, designed to extract and kill the allergenic dust mites living in mattresses, chairs, carpets and other upholstered furniture.

Domobios is the maker of Acar’up, a trap device, very easy to use, designed to extract and kill the allergenic dust mites living in mattresses, chairs, carpets and other upholstered furniture.

Ovizio develops digital holographic interferometric microscopy products. It builds 4D microscopic imaging devices and software based on digital holographic microscopy.

CluePoints® is a Risk-Based Monitoring and Central Statistical Monitoring solution that has been designed and perfected over the last 15 years. It employs unique statistical algorithms to determine the quality, accuracy, and integrity of clinical trial data both during and after study conduct. Aligned with guidance from the ICH, FDA and EMA, CluePoints® is deployed to support traditional on-site monitoring, medical review and to drive a Risk-Based Monitoring strategy. The value of using CluePoints® lies in its powerful and timely ability to identify anomalous data and site errors allowing improvement in clinical data quality, optimization of on-site monitoring and a significant reduction in overall regulatory submission risk.

neoScores is a pioneer in offering digital music scores. It gives musicians the opportunity to simply and securely purchase scores or to use and to share notes with fellow musicians, anywhere they are. Gustaf is an OS and device independent web platform that allows the distribution of digital sheet music. High in quality, easy and flexible, beautiful and stylish, Gustaf allows to use scores via smartphone, tablet or computer through any operating system. That is how neoScores® wants to change the way sheet music is used by musicians. neoScores® was founded in July 2013 by Bart Van der Roost, Bob Hamblok and Jonas Coomans, three professional musicians with a passion for new media.

Pharmafluidics is a spin-off company of the Vrije Universiteit Brussel, aiming at developing integrated milli- to nano-engineered solutions for mixing, separation and reaction processes. Rooted in chemical engineering with an advanced know-how in micro-fabrication technology, our team specializes in developing high quality and tailor-made solutions for any problem in the chemical and life sciences industry potentially benefiting from miniaturization or fine material structuring.